Achieve Life Sciences
ACHV
29 hedge funds and large institutions have $17.5M invested in Achieve Life Sciences in 2021 Q2 according to their latest regulatory filings, with 17 funds opening new positions, 8 increasing their positions, 3 reducing their positions, and 4 closing their positions.
325% more first-time investments, than exits
New positions opened: 17 | Existing positions closed: 4
167% more repeat investments, than reductions
Existing positions increased: 8 | Existing positions reduced: 3
81% more funds holding
Funds holding: 16 → 29 (+13)
50% more capital invested
Capital invested by funds: $11.7M → $17.5M (+$5.84M)
5.22% more ownership
Funds ownership: 16.38% → 21.6% (+5.2%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SC
Shay Capital
New York
|
+$2.55M |
| 2 |
PCM
Perkins Capital Management
Wayzata,
Minnesota
|
+$1.25M |
| 3 |
6CM
683 Capital Management
New York
|
+$1.19M |
| 4 |
ACM
Altium Capital Management
New York
|
+$1.16M |
| 5 |
CC
Clearline Capital
New York
|
+$1.16M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
IC
Ikarian Capital
Dallas,
Texas
|
-$3.29M |
| 2 |
Vanguard Group
Malvern,
Pennsylvania
|
-$448K |
| 3 |
BFM
Boothbay Fund Management
New York
|
-$387K |
| 4 |
Citadel Advisors
Miami,
Florida
|
-$144K |
| 5 |
TRCT
Tower Research Capital (TRC)
New York
|
-$10.2K |
ACHV Hedge Fund Activity: Q2 2021 in Review
29 of the 5,767 institutional investors tracked by Wall St. Rank reported a position in Achieve Life Sciences (ACHV) for Q2 2021, worth a combined $17.5M — up 50% from $11.7M a quarter earlier.
Buyers outnumbered sellers: 17 funds opened new ACHV positions and 4 closed out — a net gain of 13 holders — while 8 added to existing stakes and 3 trimmed.
The largest buyer was Shay Capital, adding an estimated $2.55M. The largest seller was Ikarian Capital, exiting entirely with an estimated $3.29M sold.
- 29 institutional investors held Achieve Life Sciences (ACHV) as of Q2 2021, up from 16 in Q1 2021.
- Funds reported $17.5M of Achieve Life Sciences stock for Q2 2021, up 50% quarter-over-quarter.
- 17 funds opened new Achieve Life Sciences positions in Q2 2021 and 4 closed out, a net change of +13 holders.
- The largest Achieve Life Sciences buyer in Q2 2021 was Shay Capital, an estimated $2.55M added.
- The largest Achieve Life Sciences seller in Q2 2021 was Ikarian Capital, an estimated $3.29M sold.
Based on aggregated 13F filings for Q2 2021.